Nora Schneider represents and counsels a broad range of clients, including hospitals, physician practices, ambulatory service providers, healthcare management companies, and pharmaceutical and medical device companies on healthcare regulatory, litigation, and public policy matters.

Ms. Schneider's regulatory and litigation experience includes representing and advising healthcare providers on matters related to Medicare and Medicaid fraud and abuse issues, "Stark" physician self-referral laws, and anti-kickback laws; regulatory and legislative initiatives affecting the healthcare industry; Medicare and Medicaid regulations and policies; and federal and state pharmaceutical laws. As part of her practice, Ms. Schneider represents clients in criminal and civil investigations brought by the government, as well as conducts internal investigations. Her transactional practice focuses on advising clients on the regulatory, structuring and business considerations in healthcare business transactions and contractual arrangements.


Industry Panel: Uncover Compliant Utilization of Co-pay Cards and Patient Assistance Programs in an Era of Increased Scrutiny
World Congress Patient Services Compliance Summit, Philadelphia, PA
Medicare Shared Savings Program Final ACO Fraud and Abuse Waivers: Issues of Interest for Pharmaceutical and Medical Device Manufacturers
Arnold & Porter Advisory
Chapter 4-1, FDA Regulatory Framework for Marketing Your Product

FDLI, Bringing Your Pharmaceutical Drug to Market

Chapter 4-2, Promoting Your Product

FDLI, Bringing Your Pharmaceutical Drug to Market

Frontline of Health-Care Defense: Building Credibility for Corporate Counsel in Fraud Investigations (pdf)

Bloomberg BNA's Health Care Fraud Report


  • JD, Vanderbilt University Law School, 2013
  • BA, Public Policy and American Institutions, Brown University, 2007
  • District of Columbia
  • New York

Email Disclaimer